Afficher la notice abrégée

dc.contributor.authorOrtiz Arrabal, Olimpia
dc.contributor.authorRodríguez, Mario Aníbal
dc.contributor.authorChato Astrain, Jesús 
dc.contributor.authorMartin-Piedra, Miguel Ángel 
dc.contributor.authorGarzón Bello, Ingrid Johanna 
dc.contributor.authorCarriel Araya, Víctor 
dc.contributor.authorFernández Valadés, Ricardo 
dc.contributor.authorEspaña López, Antonio
dc.contributor.authorAlaminos Mingorance, Miguel 
dc.contributor.authorRodríguez, Ismael Ángel
dc.date.accessioned2025-07-09T07:38:57Z
dc.date.available2025-07-09T07:38:57Z
dc.date.issued2025-05-19
dc.identifier.citationOrtiz-Arrabal O, Rodriguez MA, ChatoAstrain J, Martín-Piedra MÁ, Garzón I, Carriel V, et al. (2025) A comprehensive analysis of two types of xenogeneic bone particles for use in maxillofacial bone regeneration therapies. PLoS One 20(5): e0323754. [DOI: 10.1371/journal.pone.0323754]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/105135
dc.description.abstractRegeneration of maxillofacial bone structures is challenging. One strategy for bone damage repair involves using bone filler particles. This study analyzed the regenerative potential of deproteinized bone particles (DP) and collagen-based bone particles (CP) to determine the effectiveness of each biomaterial in bone repair. Structural analysis using scanning electron microscopy and 3D scanning showed that DP and CP were structurally similar, comprising a heterogeneous mixture of bone particles of varying sizes and shapes. Ex vivo analyses, including morphological evaluation, LIVE & DEAD assays, and DNA quantification, demonstrated high biocompatibility of CP and DP with human cells in both direct and indirect contact at 24, 48, and 72 hours. Both particles were grafted onto Wistar rats with a critical mandibular defect for two months. Computed tomography revealed significant defect reduction in the CP group, but not in the DP group, compared to negative controls without any bone particles. Histological analysis showed biocompatibility of both particles in vivo and identified regenerative tissue with collagen fibers and mineralized spots in CP and DP, with more mineralized spots in DP. Histochemistry and immunohistochemistry confirmed collagen, proteoglycans, and osteocalcin presence in the regeneration area of CP and DP. These results confirm the biocompatibility and potential of both particle types for maxillofacial bone regeneration, particularly CP. Future studies should assess their clinical usefulness for patients with cleft palate, mandibular damage, and other maxillofacial applications involving tissue engineering techniques.es_ES
dc.description.sponsorshipInstituto de Salud Carlos IIIes_ES
dc.description.sponsorshipMinisterio de Ciencia, Innovación y Universidadeses_ES
dc.description.sponsorshipEuropean Regional Development Fund (FEDER/ERDF)es_ES
dc.description.sponsorshipConsejería de Salud y Consumoes_ES
dc.description.sponsorshipJunta de Andalucíaes_ES
dc.description.sponsorshipSecretaria de Ciencia y Tecnología- Universidad Nacional de Córdoba, Argentinaes_ES
dc.description.sponsorshipAsociación Universitaria Iberoamericana de Postgrado y Consejería de Universidades_ES
dc.language.isoenges_ES
dc.publisherPlos Onees_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleA comprehensive analysis of two types of xenogeneic bone particles for use in maxillofacial bone regeneration therapiees_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1371/journal.pone.0323754
dc.type.hasVersionVoRes_ES


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Atribución 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Atribución 4.0 Internacional